No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BMY250110C52000
- 5.45
- +1.15+26.74%
15min DelayClose Jan 7 16:00 ET
5.45High5.45Low
5.45Open4.30Pre Close1 Volume1 Open Interest52.00Strike Price545.00Turnover0.00%IV0.54%PremiumJan 10, 2025Expiry Date5.14Intrinsic Value100Multiplier2DDays to Expiry0.31Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma11.72Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Truist Financial Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Announces Target Price $65
Truist Financial Remains a Buy on Bristol-Myers Squibb (BMY)
Bristol Late-stage Trial of Opdivo for Head and Neck Cancer Meets Endpoint
Express News | Refile-Buzz-Obesity Drugs, M&a Among Key Pharma Drivers for 2025, Berenberg Says
Should Bristol-Myers Squibb Company (NYSE:BMY) Be In Your Early Retirement Portfolio?
Bristol-Myers Squibb (NYSE:BMY) Has A Pretty Healthy Balance Sheet